TCON - TRACON Pharmaceuticals, Inc Company Short-Term Debt

TRACON Pharmaceuticals, Inc. (TCON) - corporate logo

TRACON Pharmaceuticals (TCON) develops antibody transport systems, offering subcutaneous administration of envafolimab to simplify therapy. Management independently oversees clinical trials while seeking lucrative partnerships, with the indicator standing at 0.00. This trading chart captures a period of R&D project stagnation and a decline in company activity following the cessation of primary studies.

TCON (traconpharma.com) Company Short-Term Debts history from 07/04/2022 to 08/04/2024

Analytical breakdowns and data insights for company TRACON Pharmaceuticals, Inc (TCON)

- share price and expert price forecast:
Stock Quotes TRACON Pharmaceuticals, Inc.|TCON - Analyst Forecast Prices
- market capitalization statistics:
Market Value TRACON Pharmaceuticals, Inc.|TCON - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Book Value per Share TRACON Pharmaceuticals|TCON - Book Capitalization|Market Capitalization to Book Value Ratio traconpharma.com|TCON - Cumulative Company Assets
- debt obligations and liquidity statistics:
Debt to Equity TRACON Pharmaceuticals|TCON - Long-Term Liabilities to Capital|Short-Term Debt to Equity TRACON Pharmaceuticals|TCON - Company Aggregate Debt|Debt to Book Value TRACON Pharmaceuticals, Inc.|TCON - Company Long-Term Loans and Borrowings|Company Short-Term Debt TRACON Pharmaceuticals|Quick Ratio traconpharma.com
- net income and valuation multiples indicators:
TCON - Final Profit
Fundamental valuation:TRACON Pharmaceuticals, Inc. - TCON
Mass-produced product of TRACON Pharmaceuticals

For TRACON Pharmaceuticals (TCON), which manages the complex logistics of gene research, short-term debt reflects management's ability to fund operating cycles without compromising program profitability. By analyzing this chart of current debt obligations, an investor assesses the total amount of loans maturing within one year, where a sharp spike in the indicator signals a liquidity shortage and the risk of freezing the company's free cash flow.

Competing companies

TEM: Company Current Liabilities|Qiagen NV - Amount of Current Liabilities|Ionis Pharma (IONS) - Company Short-Term Debt|Repligen Inc. - Company Short-Term Loans and Borrowings|RNA (Avidity Biosciences) - Company Short-Term Debts|Company Short-Term Debts crisprtx.com|Company Short-Term Debts WGS|Company Current Liabilities Ultragenyx Pharmaceutical Inc. RARE|Company Short-Term Debt Beam Therapeutics Corp BEAM|Sarepta Corp (SRPT) - Short-Term Debt|TWST - Company Short-Term Debt|TXG (10xgenomics.com) - Company Short-Term Indebtedness|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|Stoke Therapeutics Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt BioLife Corp|Wave Pharma - Current Liabilities|Company Short-Term Debts MAZE|SION (sionnatx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts PRME (Prime Medicine)|Company Short-Term Debts Taysha Gene Therapies Inc TSHA|QURE - Company Short-Term Debt|Company Short-Term Loans and Borrowings MGTX (MeiraGTx Corp)|REGENXBIO Inc. (RGNX) - Company Short-Term Debt|Company Current Liabilities solidbio.com|OCGN (Ocugen) - Company Short-Term Debts|Company Short-Term Debts Pacific Biosciences of California, Inc.|Company Short-Term Debts BNTC|Company Current Liabilities Design Corp DSGN|Company Short-Term Debts RCKT (Rocket Pharmaceuticals)|4dmoleculartherapeutics.com (FDMT) - Short-Term Debt|LXEO: Company Current Liabilities|KRRO - Company Short-Term Debts|EDIT (Editas) - Company Current Liabilities|SLN: Amount of Current Liabilities|PRQR (ProQR) - Company Short-Term Debts|Codexis Bio (CDXS) - Short-Term Debt Volume|Company Short-Term Debts SGMO|Company Current Liabilities nautilus.bio NAUT|Company Short-Term Debts MGX (Metagenomi, Inc)|Company Short-Term Debts precisionbiosciences.com DTIL|GBIO - Company Short-Term Debt|BOLD: Company Short-Term Debt|exicuretx.com (XCUR) - Company Short-Term Debt|IMNN - Short-Term Debt Volume|Company Current Liabilities PHIO|MBIO (Mustang Bio Corp) - Amount of Current Liabilities|Company Short-Term Debts RNAZ|Company Current Liabilities bionanogenomics.com BNGO|Company Short-Term Debt Applied DNA Sciences, Inc. APDN|bluebird bio Inc. (BLUE) - Short-Term Debt|IPA - Company Short-Term Debt|OMGA (Omega Therapeutics Corp) - Company Short-Term Indebtedness|OMIC: Company Short-Term Debts|Company Short-Term Indebtedness RGLS|Company Short-Term Debt Syros Pharmaceuticals, Inc.|Company Short-Term Indebtedness TBIO (Telesis Bio Inc.)|Company Short-Term Debts UBX